This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dvorak CC, Steinbach WJ, Brown JM, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2005;36:621–9.
Castagnola E, Bagnasco F, Bandettini R, Caviglia I, Morreale G, Lanino E, et al. Role of acute Graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a Single-Center Observational Study. Biol Blood Marrow Transplant. 2014;20:1056–73.
Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B et al. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review. J Pediatric Infect Dis Soc. 2017. May 26. https://doi.org/10.1093/jpids/pix030. [Epub ahead of print]
Kobayashi R, Kaneda M, Sato T, Suzuki D, Ichikawa M, Ariga T. Evaluation of risk factors for invasive fungal infection after allogeneic stem cell transplantation in pediatric patients. J Pediatr Hematol Oncol. 2007;29:786–91.
Hale KA, Shaw PJ, Dalla-Pozza L, MacIntyre CR, Isaacs D, Sorrell TC. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. Br J Haematol. 2010;149:263–72.
Hol JA, Wolfs TF, Bierings MB, Lindemans CA, Versluys AB, Wildt de A, et al. Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone Marrow Transplant. 2014;49:95–101.
Aftandilian C, Weinberg K, Willert J, Kharbanda S, Porteus M, Maldonado Y, et al. Invasive fungal disease in pediatric patients undergoing allogeneic hematopoietic stem cell transplant. J Pediatr Hematol Oncol. 2016;38:574–80.
Libbrecht C, Goutagny MP, Bacchetta J, Ploton C, Bienvenu AL, Bleyzac N, et al. Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation. Eur J Haematol. 2016;97:70–7.
Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B, et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 2008;41:339–47.
Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, et al. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant. 2014;20:872–88.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.
Castagnola E, Bagnasco F, Amoroso L, Caviglia I, Caruso S, Faraci M, et al. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant. A single center 30-year experience. Pediatr Infect Dis J. 2014;33:233–7.
Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B, et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 2008;41:339–47.
Castagnola E, Bagnasco F, Bandettini R, Caviglia I, Morreale G, Lanino E, et al. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study. Biol Blood Marrow Transplant. 2014;20:1068–73.
Castagnola E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G. Cytomegalovirus infection after bone marrow transplantation in children. Human Immunol. 2004;65:416–22.
Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47:1041–50.
Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, et al. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Biol Blood Marrow Transplant. 2015;21:1117–26.
Girmenia C, Barosi G, Piciocchi A, Arcese W, Aversa F, Bacigalupo A, et al. Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant. 2014;20:1080–8.
Author contributions
EC: study design, data analysis, manuscript preparation, FB: data analysis and manuscript revision, SM: data revision and analysis, MM: data collection, revision and analysis, AP: data collection and revision, TB: data collection and revision, API: data collection and revision, WB: data collection and revision, AS: data collection and revision, AP: data collection and revision, AMR: study design, data collection and revision, AV: data collection and revision, LC: data collection and revision, AR study design, manuscript revision, CG: study design, manuscript revision
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Castagnola, E., Bagnasco, F., Menoni, S. et al. Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant 53, 1193–1197 (2018). https://doi.org/10.1038/s41409-018-0160-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-018-0160-2
This article is cited by
-
Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Invasive Fungal Infections: Challenges and Indications
Current Fungal Infection Reports (2021)